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Suiamry Twenty-four out of 164 (14%) adult patients with pnrmary germ cell tumours of testis seen over the
last 6 years at the Institute Rotary Cancer Hospital (IRCH) of the All India Institute of Medical Sciences
(AIIMS), New Delhi, were found to have cryptorchidism. Only one patient had undergone correction. As a
result the testes were intra-abdominal in the vast majority, and patients presented late. Twenty-two patients
presented with stage Ilb or more advanced disease. Twelve patients had seminoma and the others had mixed
or non-seminomatous germ cell tumour (NSGCT), i.e. 50% each. The earlier patients were managed by initial
resection followed by radiation and or chemotherapy. As experience grew the seven patients who presented
late were given initial chemotherapy followed by resection in those with residual tumours. The probability of
overall survival was 0.65 at 36 months and, was not significantly different from survival in 114 patients with
tumours of normally descended testis. Early orchipexy facilitates the detection, but whether it reduces the
incidence of tumours is controversial. Uncorrected cryptorchidism is now rarely seen in the West, but in India
and many other developing countries tumours of uncorrected cryptorchid testes continue to be seen.
Keywords: germ cell tumours; uncorrected cryptorchidism; testicular cancer
Cryptorchidism occurs in approximately 1 in 500 live births.
A history of cryptorchidism is obtainable in 2.9-16.1% of
testicular tumours. Cryptorchid testis is 30-50 times more
susceptible to malignant change (Batata et al.. 1982). Accord-
ing to some. the practice of elective orchiopexy in early
childhood reduces the risk of this cancer, but there is no
universal agreement on this (Pinczowski et al.. 1981). In some
parts of India we continue to see patients in whom cryptor-
chidism is not corrected early and who go on to develop
malignancy. Tumours of the uncorrected cryptorchid testis
are now extremely rarely seen in the West. There are there-
fore very few reports on the management of such cases in the
post-cisplatin era. The aim of this presentation is to put on
record our experience with such tumours, to assess the
impact of modern management. including cisplatin-based
chemotherapy. on such tumours and briefly to compare their
presentation with tumours of normally descended testis.
Methods and Results
Case records of 164 consecutive patients with primary germ
cell tumours of testis seen over a 6 year period from June
1987 to June 1993 at IRCH, a regional cancer centre located
at AIIMS New Delhi, were analysed. In addition to routine
investigations, serum a-fetoprotein (AFP) and frhuman
chorionic gonadotrophin (P-HCG) were estimated in all
patients and computerised tomography (CT) of abdomen,
pelvis and chest was performed. Staging was done according
to the Royal Marsden Hospital (RMH) classification system
(Peckham et al., 1979). Histology was obtained on laparo-
tomy or on CT or ultrasound-guided Trucut biopsy and
reporting was done according to the WHO classification
(Mostofi and Sobin, 1977). The probability of survival was
calculated using the Kaplan-Meier method.
Clinical material
Twenty-four (14%) patients were found to have tumours in a
cryptorchid testis. The mean age was 26 years (range 17-48
years). Only one patient had undergone orchiopexy for right
inguinal testis at 5 years and developed malignant teratoma
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at 20 years. Twenty-two patients presented with abdominal
pain or masses and one with an inguinal mass. Two patients
had significant ascites with abdominal masses. The duration
of symptoms ranged from 3 to 30 months with an average of
7 months. Site, staging and histological distribution are given
in Tables I and II. In only nine patients had a correct
diagnosis of a tumour been made pnror to referral. The
management in earlier cases was complete resection and if
this was not possible. debulking or biopsy. Subsequent treat-
ment depended on histology. Patients with seminoma were
subjected to radiotherapy, and those who could not undergo
complete resection and those with bulky tumours (i.e. stage
lIc) were subjected to chemotherapy. Patients with a com-
posite tumour or NSGCT were subjected to chemotherapy.
In January 1991 this policy was changed because of the
excellent results being reported for cisplatin in germ cell
Table I Distnrbution of site and side of germ cell tumours of
cryptorchid testis in 24 patients
Unilateral undescended testis (n = 16)
Right-sided. 12; left-sided. 4
Scrotal (corrected). 1; inguinal. 1; pelvic. 6. abdominal. 8
Unilateral tumours. 5; nrght-sided. 3
Bilateral undescended testis (n = 8)
Bilateral abdominal. 6
One side abdominal and one side inguinal. 2
Bilateral tumours. 3: bilateral seminomas. 2
Table n Stage and histology of tumours in uncorrected cryptorchid
testis
Stage Patients Histology
1 4 Seminoma 2
Mature teratoma I
Seminoma+NSGCT I
IIB 2 Seminoma 2
IIC 8 Seminoma 4
Seminoma + NSGCT 4
IID 5 Seminoma 2
NSGCT 3
IV 2 NSGCT 2
Bilateral 3 Bilateral seminoma 2
One side seminoma and one side NSGCT IGerm ceN taimours im ucord ayporcid testi
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Table m Companrson of histology and stage of tumours of normally and cryptorchid testis at
IRCH-AIIMS
Normal descent (n = 130) Cryptorchid (n = 24)
Overall Overall
Stage Seminoma NSGCT Mixed stagewise (%) Seminoma NSGCT Mixed stagewise (/Oo
I 29 16 3 36 2 1 1 16
II 11 20 2 24 8 3 4 62
III 3 5 6 0 0 0
IV 8 27 6 30 2 3 21
Total 51 66 11 12 7 5
Histology overall (%)
38 50 12 - 50 29 21 -
Note: complete information on staging and histology was available in 130/140 patients in the normally
descended group.
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were not completely resectable. Patic
chemotherapy post-operatively. Therefo
absent scrotal testis and abdominal mas
investigated for germ cell tumour. Histoli
Trucut biopsy under CT or ultrasounc
therapy was given followed by resection
and orchidectomy.
Management
Of 16 patients seen before 1991, com
carried out in eight and partial resecti
seven. This was followed by radiotheral
source to regional and retroperitoneal i
Eight patients with seminoma received
three received radiotherapy and chemoth
had bulky seminoma and four others
composite tumour or NSGCT received
seven patients who received chemothera
PVB (platinum, vinblastine, bleomycin,
(vinblastine, dactinomycin, bleomycin,
(Einhorn et al., 1977; Vugrin et al., 1981
scrotal testis and mature teratoma and
treatment. This patient is alive at 30 mon
lost to follow-up after staging. Seven pat
chemotherapy. Six patients had NSG4
seminoma (stage IIC). These patients fell
nostic groups according to the EORTC
given different chemotherapy protocols
Kaye, 1992). Four patients who were in
group' received BOP-VIP (bleomycin,
VP-16, ifosfamide, platinum). The o
'intermediate prognosis group', and of
BEP (bleomycin, etoposide, platinum) ai
chemotherapy (Pizocaro et al., 1985; 1
Although four patients achieved complete radiological remis-
sion, all were subjected to laparotomy. The reasons for
operating were: (i) to remove testis affected by tumour; or (ii)
to perform orchipexy of the contralateral testis in those with
bilateral cryptorchidism. Since post-chemotherapy CT scans
3"-; C ; of all these patients were abnormal because of intra-
abdominal and intrapelvic testis, and since a residual small
tumour in or around the testis could not be excluded on CT
scan, it was essential to obtain histology in all. At surgery,
1 . which included resection of residual tumour and retro-
peritoneal lymph node dissection, three patients were found
to have no tumour and received no further treatment and
one patient had a 2 cm residual lesion in the pelvis and was
given three courses of VIP chemotherapy (Loehrer et al.,
1986). This patient is alive at 30 months. Three patients with
78 62 bilateral cryptorchidism underwent bilateral orchidectomy
either because orchiopexy in the other testis was not possible
or because the testes were markedly atrophic and there was a
umours at IRCH. 0, risk of development of tumour subsequently. Younger
patients in this group were put on maintenance testosterone
injections. Five patients are alive at 4-30 months (median
follow-up 20 months). Overall, 18 patients achieved a com-
some large tumours plete response. Five patients have died. Death in three of
.nts often required these was partly related to poor compliance. Three patients
Ire any patient with with NSGCT died of progressive disease, all had stage IV
as and or ascites was disease with pulmonary or hepatic metastases and had
ogy was obtained by received BOP-VIP chemotherapy from the beginning. The
J guidance. Chemo- other patient had a good partial remission but refused to
of residual tumour undergo resection of the residual mass and experienced
disease progression. Three patients were lost to follow-up.
The probability of overall survival was 0.65, with 14 patients
at risk at 36 months (Figure 1). There was no significant
difference in the overall survival of this group as compared
iplete resection was with the 114/140 patients with tumours of normally
ton or debulking in descended testis (P = 0.952) (excluding 26 patients in whom
py: 25 Gy by cobalt information on survival was not available). The number of
nodes in seminoma. patients in each histological and stage subgroup was small
radiotherapy alone, and management was variable. Hence, stage and histological
erapy, of whom two subgroups were not compared.
who had either a
I chemotherapy. Of
py, four were given
) and three VAB-6
platinum, endoxan)
). One patient had a
received no further
ths. One patient was
tLients received initial
CT and one bulky
I into different prog-
criterion and were
(Stoter et al., 1990;
the 'poor prognosis
oncovin, platinum-
ithers were in the
these two received
nd one received VIP
Lewis et al., 1991).
One of the most noticeable findings was that 21 of these 24
patients came from very backward areas of the country and
had never gone to school and never had a complete medical
examination. The other three patients came from urban areas
and had received education up to university level. Some
patients had been aware of the missing scrotal testis before
tumours developed but felt too shy to report it. In a series
from South Africa the incidence of cryptorchid testis among
germ cell tumours of testis was 11%. Interestingly none of
the black patients had undergone orchipexy, whereas 71% of
those of mixed race and 87% of white patients had under-
gone orchipexy (Abratt et al., 1992). The mean age of our
patients was 24 years compared with 32 years in the series
reported by Batata (1982). In a series from Bombay the age
range was 24-38 years (Kulkarni et al., 1991). The right side
v
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was common in our series, as in the senres of Batata
(1982).
Degenerative changes in cryptorchid testis begin as early as
2-3 years. suggesting that it is gonadal dysgenesis rather
than ectopy per se which increases the risk of tumours
(Batata et al.. 1982). It is not established whether orchido-
pexy abolishes the higher risk of cancer in these patients. In a
large epidemiological study it was suggested that a low
absolute risk of testicular cancer in corrected patients did not
justify surveillance after operation (Pinczowski et al.. 1981).
The age distribution of patients with cancer of undescended
testis is generally similar to those who develop germ cell
tumours on scrotal testis (Batata et al., 1982). This finding
also favours the view that failure of complete descent is not
the sole factor for the development of cancer (Kulkarni et al..
1991). There is a suggestion from some studies that patients
who undergo orchipexy before the age of 10 years have a
relatively low risk of developing tumours compared with
those who undergo correction later (Martin et al., 1979;
Strader et al., 1988). It is for these reasons that some authors
have recommended orchidectomy for unilateral undescended
testis when diagnosed after puberty (Ford et al., 1985).
In contrast to the West, where the majority of the patients
present early. only six patients had stage I disease and no
patient had stage Ila disease. All others had stage IIB-IV
disease. Many studies have revealed that chemotherapy has
as good an impact on tumours of uncorrected cryptorchid
testis as in normally descended testis. In the series by Batata
et al. (1982). 5 year survival was 61% in corrected and 63%
in uncorrected cases and 79% in seminoma and 50% in
NSGCT. Kulkarni et al. (1991) demonstrated 100% 5 year
survival in stage I and II and 33% in stage IV disease.
indicating that tumours in undescended testis respond in a
way similar to those in normally descended testis. Our results
also do not indicate any significant difference in the overall
survival of patients with tumours of cryptorchid testis as
compared with those with tumours arising from normally
descended testis in both the updated analysis as well as a
previous analysis of testicular tumours in general (Raina et
al., 1993).
Of 38 uncorrected cases in the series by Batata et al. (1982)
14 had an abdominal and 24 an inguinal testis. In the series
by Kulkami and Kamat (1991) 15 21 patients had an
inguinal testis. and Redman (1980) also found the inguen to
be the most common site. In our study 22 24 patients had a
testis located in the abdomen and pelvis.
The histology of testicular tumours in relation to the
degree of descent is also interesting. Batata et al. (1982)
encountered seminoma as the commonest category: with des-
cent of the cryptorchid testis, malignant germinomas other
than pure seminoma increased in frequency: 7% of patients
with abdominal, 37% of patients with inguinal and 72% of
patients with scrotal testis had NSGCT. A review of 724
patients treated at Royal Marsden Hospital between 1975
and 1984 showed no statistically significant difference in his-
tology between those with and without a history of
undescended testis (Pike et al.. 1986). In a more recent study
of 319 patients from the Royal London Hospital. London,
three-quarters of tumours in patients with uncorrected crypt-
orchidism were seminomas, whereas 80% of tumours in
patients with corrected cryptorchidism were malignant
teratomas. suggesting that operative correction may have
something to do with histology of these tumours (Raja et al.,
1992). In our series seminoma and NSGCT occurred almost
equally frequently. We cannot comment on the predilection
for other histological sites as very few of our patients had an
inguinal or scrotal testis. Cryptorchidism may also increase
the risk of bilateral disease, as observed by Welvaart and
Tijssen (1981). Three of our 24 patients i.e. 12%. had
bilateral tumours.
In conclusion. (i) 14% of our patients with germ cell
tumours had a cryptorchid testis, of whom 23 24 had never
undergone correction: (ii) the commonest location was intra-
abdominal, resulting in delayed diagnosis and poor risk fac-
tors: (iii) seminoma and NSGCT occurred almost in equal
proportion: (iv) there is a need for improved screening and
correction at a younger age. which will enable early diag-
nosis, thereby downstaging the tumour; (v) our data do not
indicate a significant difference in the overall survival of
patients with tumours of uncorrected cryptorchid testes as
compared with those with tumours of normally descended
testes; (vi) chemotherapy before surgery seems to be an
effective option, with surgery being reserved for residual or
refractory tumours or for orchidopexy or orchidectomy.
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